Metabolic imaging using hyperpolarized 13 C‐pyruvate to assess sensitivity to the B‐Raf inhibitor vemurafenib in melanoma cells and xenografts-Reference-Cited by-同舟云学术

Metabolic imaging using hyperpolarized 13 C‐pyruvate to assess sensitivity to the B‐Raf inhibitor vemurafenib in melanoma cells and xenografts

Published:2019-12-13 Issue:2 Volume:24 Page:1934-1944
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Acciardo Stefania¹,Mignion Lionel¹²,Lacomblez Estelle¹,Schoonjans Céline¹,Joudiou Nicolas²,Gourgue Florian¹,Bouzin Caroline³^ORCID,Baurain Jean‐François⁴,Gallez Bernard¹²^ORCID,Jordan Bénédicte F.¹²^ORCID

Affiliation:

1. Biomedical Magnetic Resonance (REMA) Group Louvain Drug Research Institute (LDRI) Université catholique de Louvain (UCLouvain) Brussels Belgium

2. Nuclear and Electron Spin Technologies (NEST) Platform Louvain Drug Research Institute (LDRI) Université catholique de Louvain (UCLouvain) Brussels Belgium

3. Imaging platform 2IP Institut de Recherche Expérimentale et Clinique (IREC) Université catholique de Louvain (UCLouvain) Brussels Belgium

4. Molecular Imaging and Radiation Oncology (MIRO) Group Institute de Recherche Expérimentale et Clinique (IREC) Université Catholique de Louvain (UCLouvain) Brussels Belgium

Funder

Fonds De La Recherche Scientifique - FNRS

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14890

Reference46 articles.

1. Mutations of the BRAF gene in human cancer

2. Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial

3. Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

4. Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma;International Journal of Molecular Sciences;2024-01-31

2. Hyperpolarized Carbon 13 MRI: Clinical Applications and Future Directions in Oncology;Radiology: Imaging Cancer;2023-09-01

3. Enhancing Cancer Diagnosis with Real-Time Feedback: Tumor Metabolism through Hyperpolarized 1-13C Pyruvate MRSI;Metabolites;2023-04-28

4. Hyperpolarized 13C-Pyruvate to Assess Response to Anti-PD1 Immune Checkpoint Inhibition in YUMMER 1.7 Melanoma Xenografts;International Journal of Molecular Sciences;2023-01-28

5. Combined HP 13C Pyruvate and 13C-Glucose Fluxomic as a Potential Marker of Response to Targeted Therapies in YUMM1.7 Melanoma Xenografts;Biomedicines;2022-03-19